BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 19434732)

  • 1. Small molecule inhibitors in children with malignant gliomas.
    Herrington B; Kieran MW
    Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
    Newton HB
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of small molecule inhibitors in high-grade glioma.
    Day SE; Waziri A
    Neurosurg Clin N Am; 2012 Jul; 23(3):407-16. PubMed ID: 22748653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
    Erman M
    J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of EGFR in malignant gliomas.
    Ye F; Gao Q; Cai MJ
    Expert Opin Ther Targets; 2010 Mar; 14(3):303-16. PubMed ID: 20148717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial review: targets for glioma treatment: from bench to bedside.
    Sanson M
    Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising new therapies for malignant gliomas.
    Fine HA
    Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted cancer therapy: promise and reality.
    Klein S; Levitzki A
    Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly targeted therapies for malignant gliomas: advances and challenges.
    Penas-Prado M; Gilbert MR
    Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.
    Newton HB
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):355-78. PubMed ID: 15877531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid cancer molecular signaling pathways and use of targeted therapy.
    Kundra P; Burman KD
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):839-53, viii. PubMed ID: 17673131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving strategies: future treatment of glioblastoma.
    Chamberlain M
    Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecularly targeted therapy for malignant glioma.
    Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
    Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule signal transduction inhibitors for the treatment of solid tumors.
    Leary A; Johnston SR
    Cancer Invest; 2007 Aug; 25(5):347-65. PubMed ID: 17661211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diffuse intrinsic brain stem glioma in children: current treatment and future directions].
    Leblond P; Vinchon M; Bernier-Chastagner V; Chastagner P
    Arch Pediatr; 2010 Feb; 17(2):159-65. PubMed ID: 20018494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
    Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
    Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.
    Chinnaiyan P; Allen GW; Harari PM
    Semin Radiat Oncol; 2006 Jan; 16(1):59-64. PubMed ID: 16378908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.